RxDoctor Payments Data

Jenny Gaworski

Family · Princeton, ILNPI 1942551312

Payments from drug & device makers

$2,193in general payments, 2019–2025

Across 152 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$545
  • Nestle Healthcare Nutrition Inc.$372
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$293
  • Takeda Pharmaceuticals U.S.A., Inc.$244
  • AbbVie$242
  • Aimmune Therapeutics, Inc.$146
  • plus $351 from 5 others

What the payments were for

  • Food & beverage$2,17999%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,193 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$57,007
Medicare patients
514
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab15$134,871
Mesalamine83$38,348
LinzessLinaclotide52$38,307
CreonLipase/Protease/Amylase11$25,847
Mesalamine ErMesalamine35$9,320
Sucralfate127$8,147
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates96$6,401
Budesonide DrBudesonide36$6,154
Ondansetron OdtOndansetron63$6,084
DexilantDexlansoprazole15$5,859
Pantoprazole Sodium337$4,648
Omeprazole316$3,574
Balsalazide Disodium21$3,529
Dicyclomine Hcl145$2,883
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl178$2,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$242$64,15463 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$244$5,85915 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$293$1,63311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.

Other family in Princeton

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →